The term "hypoxia" refers to dangerously low oxygen levels in the body. While it most often arises from medical emergencies — such as drowning or severe heart and lung conditions — its effects are unmistakable: confusion, restlessness, labored breathing, a rapid heart rate, and, in serious cases, a bluish tint to the skin. The standard medical response is straightforward: restore oxygen as quickly as possible.
Given how dangerous hypoxia can be, it may seem surprising that athletes would deliberately seek a mild version of it. Yet controlled, low-level hypoxia has long been recognized as beneficial for endurance performance. Many athletes train at high altitudes, where the air contains less oxygen per breath, in order to push their bodies to adapt. A well-known example is the 1968 Summer Olympics in Mexico City. Situated at roughly 7,350 feet above sea level, the city's thinner air posed a real challenge for competitors in endurance events. To get ahead of the problem, many athletes arrived weeks or months early to train at altitude — gradually acclimatizing their bodies so they could compete on equal footing when the Games began.
High-altitude training worked because the body responded to reduced oxygen levels by producing more red blood cells. Since red blood cells carry oxygen to the body's tissues, a higher red blood cell count — within a safe range — means more oxygen reaches working muscles, reducing fatigue and improving endurance. This physiological principle became the foundation for a more controversial practice: blood doping.
First used in competitive sports in the 1970s, blood doping exploited this same mechanism artificially. An athlete would have a quantity of their own blood drawn and stored. In response to the loss, the body would ramp up red blood cell production to compensate. The stored blood was then reinfused shortly before competition, giving the athlete a higher-than-normal red blood cell count — and, in turn, a measurable boost in endurance. The practice quickly gained traction among long-distance runners, cyclists, and swimmers. It was also, as would eventually become clear, far from risk-free.
Blood doping carries serious risks on multiple fronts. To begin with, it was banned by the International Olympic Committee in 1986, making its use in competition a sanctionable offense. Beyond the legal consequences, the procedure itself posed real medical dangers. If blood was not drawn, stored, and reinfused under strict hygienic conditions, serious infections could result. More concerning, however, was the risk of polycythemia — a condition in which the blood contains an abnormally high concentration of red blood cells. Rather than improving oxygen . . .
Join today and get access to this article and all past and present Newsletters, since September 2014. Each month you’ll get a new issue sent to your inbox. Subscribe today for only $10/month!